What does this research mean for the field?

Insulin-resistant early gestational diabetes mellitus (IR-eGDM) is associated with a higher risk of neonatal complications that are attenuated by early treatment, whereas non-IR-eGDM is associated with outcomes similar to normal glucose tolerance regardless of treatment timing. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To compare pregnancy outcomes and treatment effects among insulin-resistant early GDM, non-insulin resistant early GDM, and normal glucose tolerance women.

June 7, 2026Diabetes

2148-P: Subtyping Early GDM: Insulin-Resistant Early GDM Predicts Worse Pregnancy Outcomes but Benefits Most from Early Treatment

View Full Paper

Ask AI

Bookmark

Authors

ASArianne SweetingThe University of Sydney MHMARIE-FRANCE HIVERT JIJincy ImmanuelUniversity of North Texas

Discussion

Member takes

Implication

Randomized trial examines pregnancy outcomes in insulin-resistant early GDM, suggesting early treatment improves complications.

Key Points

To compare pregnancy outcomes and treatment effects among insulin-resistant early GDM, non-insulin resistant early GDM, and normal glucose tolerance women.
Multicenter randomized controlled trial involving pregnant women with GDM-risk factors.
Participants underwent a 75g early oral glucose tolerance test (eOGTT) and were assessed for insulin resistance using HOMA-IR thresholds.
Outcomes were analyzed using multiple logistic regression to compare eGDM subtypes and normal glucose tolerance outcomes.
IR-eGDM showed higher odds of neonatal complications such as hyperbilirubinemia requiring phototherapy (OR 2.65, 95% CI 1.40-5.03) and NICU admission (OR 1.77, 95% CI 1.07-2.91).
Delayed treatment for IR-eGDM was linked to a higher odds of neonatal adverse outcomes, including composite adverse outcomes (OR 1.93, 95% CI 1.19-3.22) and respiratory distress (OR 2.30, 95% CI 1.25-4.21).
Non-IR-eGDM outcomes were similar to those with normal glucose tolerance, regardless of treatment timing.

Cite This Study

Sweeting et al. (2026) studied this question.

synapsesocial.com/papers/6a250cd27def13d035e1d002 https://doi.org/10.2337/db26-2148-p

View Full Paper

Ask AI

Bookmark

2148-P: Subtyping Early GDM: Insulin-Resistant Early GDM Predicts Worse Pregnancy Outcomes but Benefits Most from Early Treatment

Discussion

Member takes

Implication

Key Points

Cite This Study

2148-P: Subtyping Early GDM: Insulin-Resistant Early GDM Predicts Worse Pregnancy Outcomes but Benefits Most from Early Treatment

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider